Europe small molecule active pharmaceutical ingredient (API) market accounted for $38.35 billion in 2020 and will grow by 7.7% annually over 2020-2027 owing to increasing incidences of diseases, development of companies engaged in the manufacturing of small molecule APIs, the increasing technological developments in manufacturing sector, and surge in healthcare expenditure amid COVID-19 pandemic. Highlighted with 36 tables and 53 figures, this 113-page report “Europe Small Molecule API...
Asia Pacific small molecule active pharmaceutical ingredient (API) market will grow by 9.2% annually with a total addressable market cap of $537.3 billion over 2021-2027 owing to increasing incidences of diseases, development of companies engaged in the manufacturing of small molecule APIs, the increasing technological developments in manufacturing sector, and surge in healthcare expenditure amid COVID-19 pandemic. Highlighted with 33 tables and 52 figures, this 112-page report “Asia P...
Global pharmaceutical manufacturing industry will reach $673.6 billion by 2027, growing by 12.5% annually over 2020-2027 driven by increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic. Highlighted with 85 tables and 96 figures, this 185-page report “Global Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Rou...
North America pharmaceutical manufacturing industry is expected to grow by 11.0% annually in the forecast period and reach $241.76 billion by 2027 driven by increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic. Highlighted with 26 tables and 60 figures, this 125-page report “North America Pharmaceutical Manufacturing Indus...
Europe pharmaceutical manufacturing industry accounted for $84.31 billion in 2020 and will grow by 12.9% annually over 2020-2030 driven by increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic. Highlighted with 36 tables and 64 figures, this 131-page report “Europe Pharmaceutical Manufacturing Industry 2020-2027 by Formulat...
Asia Pacific pharmaceutical manufacturing industry will grow by 14.8% annually with a total addressable market cap of $1,034.6 billion over 2021-2027 driven by increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic. Highlighted with 33 tables and 63 figures, this 130-page report “Asia Pacific Pharmaceutical Manufacturing Ind...
ASEAN pharmaceutical manufacturing industry will grow by 12.8% annually with a total addressable market cap of $148.3 billion over 2021-2027 driven by increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic. Highlighted with 25 tables and 39 figures, this 66-page report “ASEAN Pharmaceutical Manufacturing Market 2017-2027 by Formulation and Country: T...
Global healthcare 3D printing market will reach $12.75 billion by 2030, growing by 22.8% annually over 2020-2030 driven by technological advancements in the medical 3D printing technology, rising investments in the healthcare sector, and the rising adoption of 3D printed medical implants, medical devices and bio printed organoids. Highlighted with 90 tables and 103 figures, this 191-page report “3D Printing in Healthcare: Global Market 2020-2030 by Component, Process and Technology, App...
North America healthcare 3D printing market is expected to grow by 21.6% annually in the forecast period and reach $5,003.8 million by 2030 driven by technological advancements in the medical 3D printing technology, rising investments in the healthcare sector, and the rising adoption of 3D printed medical implants, medical devices and bio printed organoids. Highlighted with 31 tables and 67 figures, this 128-page report “3D Printing in Healthcare: North America Market 2020-2030 by Compo...
Europe healthcare 3D printing market accounted for $503.7 million in 2020 and will grow by 22.3% annually over 2020-2030 owing to the technological advancements in the medical 3D printing technology, rising investments in the healthcare sector, and the rising adoption of 3D printed medical implants, medical devices and bio printed organoids. Highlighted with 41 tables and 71 figures, this 134-page report “3D Printing in Healthcare: Europe Market 2020-2030 by Component, Process and Techn...